Universal Beteiligungs und Servicegesellschaft mbH Lowers Stock Holdings in Option Care Health, Inc. $OPCH

Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 43.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 88,388 shares of the company’s stock after selling 66,956 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Option Care Health were worth $2,818,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in OPCH. V Square Quantitative Management LLC purchased a new position in shares of Option Care Health during the fourth quarter valued at approximately $25,000. Cornerstone Planning Group LLC lifted its holdings in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after purchasing an additional 1,067 shares during the last quarter. Advisory Services Network LLC purchased a new position in shares of Option Care Health during the third quarter valued at approximately $35,000. McIlrath & Eck LLC purchased a new position in Option Care Health in the 2nd quarter worth approximately $37,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Option Care Health in the 3rd quarter worth approximately $38,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on OPCH shares. Truist Financial set a $40.00 price objective on shares of Option Care Health in a report on Tuesday, January 13th. Citigroup restated an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. TD Cowen restated a “hold” rating on shares of Option Care Health in a report on Tuesday, January 27th. National Bank Financial set a $37.00 price objective on shares of Option Care Health in a report on Tuesday, January 27th. Finally, Morgan Stanley boosted their price objective on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a report on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $37.00.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $20.33 on Friday. Option Care Health, Inc. has a twelve month low of $18.01 and a twelve month high of $36.80. The firm has a market cap of $3.19 billion, a P/E ratio of 15.88, a PEG ratio of 1.50 and a beta of 0.95. The company has a 50 day moving average of $29.15 and a 200 day moving average of $30.69. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.46. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.44 EPS. As a group, research analysts expect that Option Care Health, Inc. will post 1.69 EPS for the current fiscal year.

More Option Care Health News

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Q1 EPS slightly beat consensus: Option Care reported $0.40 EPS vs. consensus ~ $0.39, matching prior?year EPS — a modest pocket of positive surprise. Q1 Earnings Beat (Zacks)
• Neutral Sentiment: Calls and disclosures available: the company held an earnings call and filed a press release/slide deck with details—useful for parsing management commentary and assumptions behind guidance. Earnings Call Transcript (Seeking Alpha)
• Negative Sentiment: Revenue miss in Q1 and full?year revenue guidance trimmed: Q1 revenue $1.35B vs. estimates ~$1.40B, and FY?2026 revenue guide narrowed to ~$5.7–5.8B versus street ~$5.9B — the revenue shortfall and guide cut are the primary catalysts for the selloff. Revenue Miss & Stock Slide (Seeking Alpha)
• Negative Sentiment: Legal/investigator overhang: multiple plaintiff firms and a securities?law investigation (Holzer & Holzer, Block & Leviton, Johnson Fistel) have announced inquiries tied to the results and guidance, increasing short?term uncertainty and potential legal costs. Holzer Investigation (GlobeNewswire) Block & Leviton Alert (GlobeNewswire) Johnson Fistel Alert (GlobeNewswire)
• Negative Sentiment: Market reaction and volume: the stock sold off sharply on heavy volume after the release, reflecting investor concern about revenue momentum and the added legal overhang. Market Reaction (Yahoo)

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.